Ikarian Capital »

Biohaven shares owned by Ikarian Capital

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $16M 326k 49.97
2024-03-31 $12M 224k 54.69
2023-09-30 $2.8M 106k 26.01
2023-06-30 $16M 652k 23.92
2023-03-31 $6.1M 448k 13.66
2022-12-31 $12M 838k 13.88

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Biohaven

Vanguard Group
BlackRock
Henderson Group
Stifel Financial
Suvretta Capital Management
Farallon Capital Management
State Street Corporation
T. Rowe Price Associates
RP Management
FMR
Bellevue Group
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Armistice Capital

View all funds holding Biohaven